IgG Glycosylation Analysis in Patients with Ring14 Syndrome Unveils Novel Pathomechanisms and New Therapy Perspectives
Biomolecules · 22.05.2026 · 16 (6) · 760
DOI: 10.3390/biom16060760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 22.05.2026. Verfasst von Angela Messina und 9 weiteren Autor:innen. Beteiligte Einrichtung: CNR-Institute for Polymers, Composites and Biomaterials (IPCB), 95126 Catania, Italy. Hauptthemen laut MEDLINE: Immunoglobulin G. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of University and Research-PRIN, European Union—Next Generation EU, Mission 4 Component 1, Project “NGLYNEU”, Ministry of University and Research—PRIN (Research Projects of National Relevant Interest) 2022.
Abstract (Originalsprache)
Ring chromosome 14 (RC14) syndrome is an ultra-rare disorder characterized by drug-resistant epilepsy, intellectual disabilities, autism, and recurrent infections, suggesting a possible underlying immune dysregulation. We analyzed immunoglobulin G (IgG) N-glycosylation profiles in six RC14 patients and compared them with age-matched healthy controls using ultra-high-performance liquid chromatography (UHPLC) coupled with fluorescence detection (FLR) and high-resolution electrospray ionization mass spectrometry (ESI-MS). Patients showed decreased galactosylation and sialylation, resembling pro-inflammatory patterns observed in autoimmune diseases. These alterations were not observed in total serum glycoproteins, indicating a selective effect on IgG. One patient treated with intravenous immunoglobulin (IVIG) showed clinical improvement, which led us to investigate causality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CNR-Institute for Polymers, Composites and Biomaterials (IPCB), 95126 Catania, Italy.
- CNR-Institute for Biomedical Research and Innovation (IRIB), 95126 Catania, Italy.
- Ring14 Italy, Via Flavio Gioia 5, 42124 Reggio Emilia, Italy.
- Kaleidos SCS, Scientific Office, Via Andrea Moretti, 24121 Bergamo, Italy.
- Azienda Unità Sanitaria Locale di Reggio Emilia, 42122 Reggio Emilia, Italy.
- Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy.
ORCID-Profile: Angela Messina, Angelo Palmigiano, Luisa Sturiale, Marco Crimi, Alessandro Vaisfeld, Rita Barone, Domenico Garozzo
Förderung
- Ministry of University and Research-PRIN
- European Union—Next Generation EU, Mission 4 Component 1, Project “NGLYNEU”
- Ministry of University and Research—PRIN (Research Projects of National Relevant Interest) 2022
Zitieren
APA
Messina, A., Palmigiano, A., Romeo, D. A., Sturiale, L., Parano, E., Crimi, M., Cirillo, A. C., Vaisfeld, A., Barone, R., & Garozzo, D. (2026). IgG Glycosylation Analysis in Patients with Ring14 Syndrome Unveils Novel Pathomechanisms and New Therapy Perspectives. Biomolecules, 16(6), 760. https://doi.org/10.3390/biom16060760
Vancouver
Messina A, Palmigiano A, Romeo DA, Sturiale L, Parano E, Crimi M, et al. IgG Glycosylation Analysis in Patients with Ring14 Syndrome Unveils Novel Pathomechanisms and New Therapy Perspectives. Biomolecules. 2026;16(6):760. doi:10.3390/biom16060760
BibTeX
@article{Messina2026,
author = {Messina, Angela and Palmigiano, Angelo and Romeo, Donata Agata and Sturiale, Luisa and Parano, Enrico and Crimi, Marco and Cirillo, Annunziata Carrese and Vaisfeld, Alessandro and Barone, Rita and Garozzo, Domenico},
title = {IgG Glycosylation Analysis in Patients with Ring14 Syndrome Unveils Novel Pathomechanisms and New Therapy Perspectives},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {760},
doi = {10.3390/biom16060760}
}
EUVIMED